220 related articles for article (PubMed ID: 25695198)
1. Solvent/detergent-treated plasma: a tale of 30 years of experience.
Liumbruno GM; Marano G; Grazzini G; Capuzzo E; Franchini M
Expert Rev Hematol; 2015 Jun; 8(3):367-74. PubMed ID: 25695198
[TBL] [Abstract][Full Text] [Related]
2. Solvent/detergent plasma: pharmaceutical characteristics and clinical experience.
Liumbruno GM; Franchini M
J Thromb Thrombolysis; 2015 Jan; 39(1):118-28. PubMed ID: 24844804
[TBL] [Abstract][Full Text] [Related]
3. [Clinical use of virally inactived plasma. The experience of Blood Transfusion Unit in Mantova, Italy].
Lepri D; Capuzzo E; Mattioli AV; Dall'Oglio D; Sgarioto V; Terenziani I; Caramaschi G; Manzato F; Franchini M
Recenti Prog Med; 2013 Mar; 104(3):106-11. PubMed ID: 23548954
[TBL] [Abstract][Full Text] [Related]
4. Virus inactivation by solvent/detergent treatment and the manufacture of SD-plasma.
Horowitz B; Lazo A; Grossberg H; Page G; Lippin A; Swan G
Vox Sang; 1998; 74 Suppl 1():203-6. PubMed ID: 9789529
[TBL] [Abstract][Full Text] [Related]
5. Solvent/detergent treatment of human plasma--a very robust method for virus inactivation. Validated virus safety of OCTAPLAS.
Biesert L; Suhartono H
Vox Sang; 1998; 74 Suppl 1():207-12. PubMed ID: 9789530
[TBL] [Abstract][Full Text] [Related]
6. [Detection of B19 parvovirus in plasma pools before solvent-detergent treatment of plasma: AFSSAPS and EFS Aquitaine-Limousin's experience].
Petermann R; Piquet Y; Lapeyre M; Goujon N; Gauthier M; Lalanne V; Mouillot L; Tissier MH; Boiron JM
Transfus Clin Biol; 2010 Apr; 17(2):54-62. PubMed ID: 20674438
[TBL] [Abstract][Full Text] [Related]
7. Coagulation factor content of solvent/detergent plasma compared with fresh frozen plasma.
Doyle S; O'Brien P; Murphy K; Fleming C; O'Donnell J
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):283-7. PubMed ID: 12695752
[TBL] [Abstract][Full Text] [Related]
8. Virus inactivation of fresh plasma.
Mohr H
Vox Sang; 1998; 74 Suppl 2():171-2. PubMed ID: 9704442
[No Abstract] [Full Text] [Related]
9. Virally inactivated fresh frozen plasma.
Williamson LM; Allain JP
Vox Sang; 1995; 69(3):159-65. PubMed ID: 8578727
[TBL] [Abstract][Full Text] [Related]
10. Manufacture and composition of fresh frozen plasma and virus-inactivated therapeutic plasma preparations: correlation between composition and therapeutic efficacy.
Hellstern P; Haubelt H
Thromb Res; 2002 Oct; 107 Suppl 1():S3-8. PubMed ID: 12379286
[TBL] [Abstract][Full Text] [Related]
11. Solvent/detergent-treated plasma: a virus-inactivated substitute for fresh frozen plasma.
Horowitz B; Bonomo R; Prince AM; Chin SN; Brotman B; Shulman RW
Blood; 1992 Feb; 79(3):826-31. PubMed ID: 1310064
[TBL] [Abstract][Full Text] [Related]
12. [Activity and concentration determinations of coagulation factors in conventional and virus-inactivated coagulation-active plasma].
Lutze G; Hartung KJ
Beitr Infusionsther Transfusionsmed; 1994; 32():415-8. PubMed ID: 9480135
[TBL] [Abstract][Full Text] [Related]
13. Safety and cost-effectiveness of solvent-detergent-treated plasma. In search of a zero-risk blood supply.
AuBuchon JP; Birkmeyer JD
JAMA; 1994 Oct; 272(15):1210-4. PubMed ID: 7933351
[TBL] [Abstract][Full Text] [Related]
14. Solvent-detergent-treated fresh frozen plasma: a superior alternative to standard fresh frozen plasma?
Sharma AD; Sreeram G; Erb T; Grocott HP
J Cardiothorac Vasc Anesth; 2000 Dec; 14(6):712-7. PubMed ID: 11139117
[No Abstract] [Full Text] [Related]
15. Inactivation of virus in intravenous immunoglobulin G using solvent/detergent treatment and pasteurization.
Aghaie A; Pourfatollah AA; Bathaie SZ; Moazzeni SM; Khorsand Mohammad Pour H; Sharifi Z
Hum Antibodies; 2008; 17(3-4):79-84. PubMed ID: 19029665
[TBL] [Abstract][Full Text] [Related]
16. [Preliminary results of a prospective randomized clinical study on the comparison of solvent- and detergent-inactivated plasma (SDP-TNBT/Triton X-100) and untreated fresh-frozen plasma].
Mortelmans Y; Beck KH; Kretschmer V
Beitr Infusionsther Transfusionsmed; 1994; 32():419-21. PubMed ID: 9480136
[TBL] [Abstract][Full Text] [Related]
17. Analysis of human plasma products: polymerase chain reaction does not discriminate between live and inactivated viruses.
Hilfenhaus J; Gröner A; Nowak T; Weimer T
Transfusion; 1997 Sep; 37(9):935-40. PubMed ID: 9308641
[TBL] [Abstract][Full Text] [Related]
18. Virus safety of pooled fresh-frozen plasma inactivated by solvent/detergent treatment.
Prince AM; Horowitz B
Beitr Infusionsther; 1993; 31():21-4. PubMed ID: 7693256
[No Abstract] [Full Text] [Related]
19. Enveloped virus inactivation by caprylate: a robust alternative to solvent-detergent treatment in plasma derived intermediates.
Korneyeva M; Hotta J; Lebing W; Rosenthal RS; Franks L; Petteway SR
Biologicals; 2002 Jun; 30(2):153-62. PubMed ID: 12127317
[TBL] [Abstract][Full Text] [Related]
20. Fibrinolysis during liver transplantation is enhanced by using solvent/detergent virus-inactivated plasma (ESDEP).
de Jonge J; Groenland TH; Metselaar HJ; IJzermans JN; van Vliet HH; Visser L; Tilanus HW
Anesth Analg; 2002 May; 94(5):1127-31, table of contents. PubMed ID: 11973173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
